Nature of the Collaboration Clause Samples

The "Nature of the Collaboration" clause defines the fundamental structure and intent of the working relationship between the parties involved. It typically clarifies whether the collaboration is a partnership, joint venture, or another form of association, and outlines the scope, objectives, and boundaries of the joint activities. By explicitly stating the nature of the relationship, this clause helps prevent misunderstandings about roles, responsibilities, and liabilities, ensuring all parties have a clear and shared understanding of how they will work together.
POPULAR SAMPLE Copied 1 times
Nature of the Collaboration. Subject to the terms and conditions of this Agreement, Introgen shall conduct research and development activities directed to the Field as part of a collaborative Program as set forth herein. As between the Parties, Introgen shall be responsible for conducting the research and development activities of the Program and shall keep Colgate informed, through the Steering Committee described below, as to the progress thereof, and will consult with the Steering Committee regarding the direction and goals of the Program, all as described in this Article 2. In addition, Colgate may from time to time undertake additional activities relating to the Program, as Colgate may determine or the Parties agree, and will keep the Steering Committee informed of those activities.
View Source
Nature of the Collaboration. Company and Partner agree to use their good faith, reasonable efforts to engage in mutually beneficial collaboration in support of the Project as set out in Exhibit A (Description of technical partnership and responsibilities) and Exhibit B (Description of initiatives around PR and co-marketing).
View SourceView Similar (3)
Nature of the Collaboration. 3.1. DAISI will provide: 3.1.1. Visiting specialist doctors free of charge for one to two week visits to public hospitals (Tungara Central, Southern Kiribati, Kiritimati and Betio Hospitals) when requested and adequately prepared for by Kiribati Ministry for Health. 3.2. Tungaru Central Hospital and the GoV will provide: 3.2.1. Provision of administrative support for the project, including but not limited to any exemption request towards DAISI specialist training missions project supplies or DAISI project personnel; and 3.2.2. In country administrative support for organisation of support to activities in liaison with DAISI personnel. 3.2.3. Free registration to DAISI members who meet criteria for temporary medical and nursing registration to practice in Kiribati 3.2.4. Necessary screening and recruitment of patients for specialist visits. 3.2.5. Necessary medical and nursing staff to ensure the safe delivery of specialist services and teaching. 3.2.6. Doctors from Kiribati to attend DAISI specialists training missions who specifically require training in specialty areas of medicine and surgery in order for DAISI to meet its key objective of training local doctors.
View SourceView Similar (3)
Nature of the Collaboration. The parties are entering into this MOU on the basis that they are equal partners who bring different and yet complementary strengths to the tasks of: • creating “pro-poor” cities that integrate rather than marginalize the interests of informal workers and dwellers, and countering the dominant urban development approaches which so often exclude them; • collaborating (in the cities and towns of Africa where AAPS member schools have a presence) to expose students of city/town/regional planning to the issues and needs of informal workers, so that as professionals they will work directly or indirectly to promote inclusive and pro-poor urban settlements; • exchanging ideas on the development of curricula in planning and the built environment. • undertaking joint research and collaboration on the documentation and dissemination of successful cases of pro-poor intervention, and information exchange, for use in teaching and to influence policy-makers. The two organisations commit themselves to the common goal of jointly delivering to the highest level of quality. Their relationship in taking forward this goal will be underpinned by principles of transparency and trust. All research and publication collaborations will adhere to the principles of ethical research, the right to privacy and informed consent. This includes sensitivity to cultural diversity, confidentiality and anonymity. It is acknowledged that both institutions have different agendas and processes, but are partnering towards a common goal. In the spirit of the collaboration, each entity will respect the autonomy, experience and timelines of the other. It is intended that the collaboration is undertaken with the Partners equally sharing risks and benefits associated with the objectives of the collaboration. The use of the term “Partner” in this agreement is not intended in a way that implies the creation of a legal partnership, joint venture or any other kind of legal entity between (AAPS) and (WIEGO) in order to implement the collaboration. It is rather used to express a collaboration in which both members have equal status.
View SourceView Similar (2)
Nature of the Collaboration. This MoU describes the framework for the future management of works within Reserves by DWAG, dependant on contract renewal.  DWAG is required to maintain its legal identity, public liability and workers compensation insurance policies.  DWAG are encouraged to seek grant funding on behalf of the Shire from Federal, State and/or other agencies to work in Denmark’s Reserves to help maintain biodiversity.  To facilitate communication between DWAG, contractors and Shire employees working in Reserves to ensure that all works are conducted in a manner that maximises the resources used to fund and conduct works within Reserves on a priority basis.  To ensure that contractors and Shire employees are aware of the location and extent of works conducted by DWAG and funded by Federal, State and Local Government bodies.  To ensure that integrated weed management is effective.
View Source
Nature of the Collaboration. 3.1. DAISI will provide: 3.1.1. Visiting specialist doctors free of charge for one to two week visits to public hospitals (VCH & NPH) when requested and adequately prepared for by Vanuatu Ministry for Health. 3.2. The GoV will provide: 3.2.1. Provision of administrative support for the project, including but not limited to any exemption request towards DAISI specialist training missions project supplies or DAISI project personnel; and 3.2.2. In country administrative support for organisation of support to activities in liaison with DAISI personnel. 3.2.3. Free registration to DAISI members who meet criteria for temporary medical and nursing registration to practice in Vanuatu. 3.2.4. Necessary screening and recruitment of patients for specialist visits. 3.2.5. Necessary medical and nursing staff to ensure the safe delivery of specialist services and teaching. 3.2.6. Doctors from Vanuatu to attend DAISI specialists training missions who specifically require training in specialty areas of medicine and surgery in order for DAISI to meet its key objective of training local doctors.
View Source
Nature of the Collaboration. 3.1. DAISI will provide: 3.1.1. Visiting specialist doctors free of charge for one to two week visits to Sopas District and Enga Provincial hospitals when requested and adequately prepared for by Sopas District and Enga Provincial Hospitals(PNG) and the Enga Province Health Authority (EPHA) 3.2. The Sopas District and Enga Provincial Hospital will provide: 3.2.1. Provision of administrative support for the project, including but not limited to any exemption request towards DAISI specialist training missions project supplies or DAISI project personnel; and 3.2.2. In country administrative support for organisation of support to activities in liaison with DAISI personnel. 3.2.3. Free registration to DAISI members who meet criteria for temporary medical and nursing registration to practice in PNG. 3.2.4. Necessary screening and recruitment of patients for specialist visits. 3.2.5. Necessary medical and nursing staff to ensure the safe delivery of specialist services and teaching. 3.2.6. Doctors from Sopas District and Enga Provincial Hospitals (PNG) to attend DAISI specialists training missions who specifically require training in specialty areas of medicine and surgery in order for DAISI to meet its key objective of training local doctors.
View Source

Related to Nature of the Collaboration

  • Collaboration activities 4.1 The Collaboration Suppliers will perform the Collaboration Activities and all other obligations of this Agreement in accordance with the Detailed Collaboration Plan. 4.2 The Collaboration Suppliers will provide all additional cooperation and assistance as is reasonably required by the Buyer to ensure the continuous delivery of the services under the Call-Off Contract. 4.3 The Collaboration Suppliers will ensure that their respective subcontractors provide all cooperation and assistance as set out in the Detailed Collaboration Plan.

  • Research Collaboration Upon FibroGen’s request, the Parties will discuss conducting a research program funded by AstraZeneca and directed toward franchise enhancement and lifecycle management for HIF Compounds or other topics that the Parties determine relevant to the Products and the Field. Upon agreement on the terms of such research program, the Parties will enter into a separate agreement or amend this Agreement accordingly.

  • Scope of Collaboration As part of the collaboration, the Controllers will act as Joint Controller. The roles of the Controller and the associated tasks are specified in more detail in Appendix 1. If one party is solely responsible for a data processing operation, this party will implement all relevant data protection provisions on its own responsibility. However, such data processing procedures are not subject to this Agreement. Joint data processing and the type of Personal Data collected and processed within the framework of collaboration are specified in Appendix 1.

  • Collaboration 31.1 If the Buyer has specified in the Order Form that it requires the Supplier to enter into a Collaboration Agreement, the Supplier must give the Buyer an executed Collaboration Agreement before the Start date. 31.2 In addition to any obligations under the Collaboration Agreement, the Supplier must: 31.2.1 work proactively and in good faith with each of the Buyer’s contractors 31.2.2 co-operate and share information with the Buyer’s contractors to enable the efficient operation of the Buyer’s ICT services and G-Cloud Services

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).